Xian-Janssen And Nanjing Medical Resume Collaboration On Drug Distribution
This article was originally published in PharmAsia News
Executive Summary
Nanjing Medical and Xian-Janssen have ended their dispute over drug distribution (PharmAsia News, March 31, 2008), according to an insider, but the detailed compromise solution is not disclosed. The strained relations between the two firms have impacted Xian-Janssen's revenue, which dropped 20 to 30 percent in 2008. Based on the previous model, Nanjing Medical is now directly distributing Xian-Janssen's drugs in Fujian and Anhui provinces. However, Jiangsu is covered by Nanjing Huadong Medicine, which is Nanjing Medical's sister subsidiary under Nanjing Medical Industry (Group). The move shows Xian-Janssen's willingness to work indirectly with Nanjing Medical to avoid losing the latter's Jiangsu clients comprising 167 hospital pharmacies. (Click here for more - Chinese Language)